"Intestinal Polyps" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Discrete abnormal tissue masses that protrude into the lumen of the INTESTINE. A polyp is attached to the intestinal wall either by a stalk, pedunculus, or by a broad base.
| Descriptor ID |
D007417
|
| MeSH Number(s) |
C23.300.825.411
|
| Concept/Terms |
Intestinal Polyps- Intestinal Polyps
- Intestinal Polyp
- Polyp, Intestinal
- Polyps, Intestinal
|
Below are MeSH descriptors whose meaning is more general than "Intestinal Polyps".
Below are MeSH descriptors whose meaning is more specific than "Intestinal Polyps".
This graph shows the total number of publications written about "Intestinal Polyps" by people in this website by year, and whether "Intestinal Polyps" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Intestinal Polyps" by people in Profiles.
-
Molecular markers of carcinogenesis for risk stratification of individuals with colorectal polyps: a case-control study. Cancer Prev Res (Phila). 2014 Oct; 7(10):1023-34.
-
Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice. J Pharmacol Exp Ther. 2014 Jul; 350(1):99-109.
-
Expression of ROR?t marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med. 2012 Dec 12; 4(164):164ra159.
-
Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res. 2008 Nov; 6(11):1786-93.
-
Regulation of prostaglandin transporters in colorectal neoplasia. Cancer Prev Res (Phila). 2008 Jul; 1(2):93-9.
-
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer Res. 2007 Oct 01; 67(19):9380-8.
-
Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression. Proc Natl Acad Sci U S A. 2006 Dec 12; 103(50):19069-74.
-
FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor. J Surg Oncol. 2004 Sep 15; 87(4):187-90.
-
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nat Med. 2004 Mar; 10(3):245-7.
-
Massive screening for colorectal cancer. A single institution's public commitment. Arch Surg. 1990 Aug; 125(8):1049-51.